PT  - JOURNAL ARTICLE
AU  - Powers, Jenny
ED  - Horneff, Gerd
TI  - Long-Term Adalimumab is Safe and Achieves Disease Control in Children with Advanced and Refractory JIA
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 13--14
VI  - 14
IP  - 17
4099  - http://mdc.sagepub.com/content/14/17/13.short
4100  - http://mdc.sagepub.com/content/14/17/13.full
AB  - Long-term disease control was observed with adalimumab administered in routine clinical practice to patients with moderately to severely active juvenile idiopathic arthritis (JIA). This article discusses interim findings from an analysis done at 4 years from an ongoing international registry of patients enrolled upon diagnosis of moderately to severely active JIA [NCT00783510].